Background: Knowing the status of the internal mammary lymph (IML) nodes is important for accurate staging and appropriate selection of subsequent treatment in breast cancer. We conducted a meta-analysis to clarify the rate of IML node metastasis in breast cancer patients and discussed the importance of this finding. Methods: We retrieved articles from the literature that reported positive rates of IML node metastasis in breast cancer patients. The quality of the selected articles was assessed using the ‘Methodological Index for Non-Randomized Studies'. The heterogeneity was tested, and publication bias was assessed using a funnel plot. Finally, the positive rate of IML node metastasis in breast cancer patients was calculated using the random-effects model. Results:15 articles met the inclusion criteria and a total of 4,248 patients were included in the analysis. Heterogeneity across the studies was statistically significant (p = 0.014); thus, the random-effects model was used and the calculated positive rate of IML node metastasis was 23% (95% confidence interval (CI), 0.21-0.25). Conclusions: Approximately 23% of the breast cancer patients had IML node metastases, for which the prognosis is generally poor. Accurate staging and integrated treatment are necessary to improve the survival of these patients.

1.
Kuehn T, Vogl FD, Helms G, Pueckler SV, Schirrmeister H, Strueber R, Koretz K, Kreienberg R; German multi-institutional trial: Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective German multi-institutional trial. Eur J Surg Oncol 2004;30:252-259.
2.
Yao MS, Kurland BF, Smith AH, Schubert EK, Dunnwald LK, Byrd DR, Mankoff DA: Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer. Ann Surg Oncol 2007;14:2985-2993.
3.
National Comprehensive Cancer Network: Breast Cancer Version 2012;2. www.nccn.org.
4.
Bass SS, Lyman GH, McCann CR, Ku NN, Berman C, Durand K, Bolano M, Cox S, Salud C, Reintgen DS, Cox CE: Lymphatic mapping and sentinel lymph node biopsy. Breast J 1999;5:288-295.
5.
Lamonica D, Edge SB, Hurd T, Proulx G, Stomper PC: Mammographic and clinical predictors of drainage patterns in breast lymphoscintigrams obtained during sentinel node procedures. Clin Nucl Med 2003;28:558-564.
6.
Saarnak AE, Hurkmans CW, Pieters BR, Valdes Olmos RA, Schultze Kool LJ, Hart AA, Muller SH: Accuracy of internal mammary lymph node localization using lymphoscintigraphy, sonography and CT. Radiother Oncol 2002;65:79-88.
7.
Avisar E, Molina MA, Scarlata M, Moffat FL: Internal mammary sentinel node biopsy for breast cancer. Am J Surg 2008;196:490-494.
8.
Noguchi M: Internal mammary sentinel node biopsy for breast cancer: is it practicable and relevant? (Review). Oncol Rep 2002;9:461-468.
9.
Cranenbroek S, van der Sangen MJ, Kuijt GP, Voogd AC: Diagnosis, treatment and prognosis of internal mammary lymph node recurrence in breast cancer patients. Breast Cancer Res Treat 2005;89:271-275.
10.
Maalej M, Gargouri W, Kochbati L, Nasr C, Frikha H, Hentati D, Elkadri N, Kraiem T, Chebbi A, Saadi A, Mrad K, Zakhama A, Hechiche M, Ben Romdhane K: [Internal mammary lymph node invasion in breast cancer: Myth or reality?] Tunis Med 2009;87:319-322.
11.
Sutton AJ, Abrams KR, Jones DR, Jones DR, Sheldon TA, Song F: Methods for Meta-Analysis in Medical Research. New York, John Wiley & Sons, 2000.
12.
Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J: Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 2003;73:712-716.
13.
Margotti: The natural history of breast carcinoma; in Haagensen CD (ed): Diseases of the Breast. Philadelphia, Saunders, 1986; pp 635-718.
14.
Handley RS, Thackray AC: Invasion of internal mammary lymph nodes in carcinoma of the breast. Br Med J 1954;1:61-63.
15.
Hutchinson WB, Kiriluk LB: Internal mammary node investigation in carcinoma of the breast. Am J Surg 1956;92:151-155.
16.
Caceres E: Incidence of metastasis in the internal mammary chain in operable cancer of the breast. Surg Gynecol Obstet 1959;108:715-720.
17.
Bucalossi P, Veronesi U, Zingo L, Cantu C: Enlarged mastectomy for breast cancer. Review of 1,213 cases. Am J Roentgenol Radium Ther Nucl Med 1971;111:119-122.
18.
Donegan WL: The influence of untreated internal mammary metastases upon the course of mammary cancer. Cancer 1977;39:533-538.
19.
Veronesi U, Cascinelli N, Greco M, Bufalino R, Morabito A, Galluzzo D, Conti R, De Lellis R, Delle Donne V, Piotti P, et al.: Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 1985;202:702-707.
20.
Horino T, Fujita M, Ueda N, Ota J, Ryo M, Nakano Y, Taguchi T: Efficacy of internal mammary node dissection in the treatment of breast cancer. Jpn J Clin Oncol 1991;21:422-427.
21.
Cody HS 3rd, Urban JA: Internal mammary node status: a major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol 1995;2:32-37.
22.
Sugg SL, Ferguson DJ, Posner MC, Heimann R: Should internal mammary nodes be sampled in the sentinel lymph node era? Ann Surg Oncol 2000;7:188-192.
23.
Dupont E, Cox CE, Nguyen K, Salud CJ, Peltz ES, Whitehead GF, Ebert MD, Ku NN, Reintgen DS: Utility of internal mammary lymph node removal when noted by intraoperative gamma probe detection. Ann Surg Oncol 2001;8:833-836.
24.
van der Ent FW, Kengen RA, van der Pol HA, Povel JA, Stroeken HJ, Hoofwijk AG: Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg 2001;234:79-84.
25.
Madsen E, Gobardhan P, Bongers V, Albregts M, Burgmans J, De Hooge P, Van Gorp J, van Dalen T: The impact on post-surgical treatment of sentinel lymph node biopsy of internal mammary lymph nodes in patients with breast cancer. Ann Surg Oncol 2007;14:1486-1492.
26.
Heuts EM, van der Ent FW, Hulsewe KW, von Meyenfeldt MF, Voogd AC: Results of tailored treatment for breast cancer patients with internal mammary lymph node metastases. Breast 2009;18:254-258.
27.
Long H, Lin Z, Situ D, Ma G, Zheng Y, Rong T: Stage migration and therapy modification after thoracoscopic internal mammary lymph node dissection in breast cancer patients. Breast 2011;20:129-133.
28.
Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-1101.
29.
Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
30.
Freedman GM: Radiation therapy for operable breast cancer: sixty years of progress as seen through the articles published in the journal Cancer. Cancer 2008;113:1779-1800.
31.
Zhang YJ, Oh JL, Whitman GJ, Iyengar P, Yu TK, Tereffe W, Woodward WA, Perkins G, Buchholz TA, Strom EA: Clinically apparent internal mammary nodal metastasis in patients with advanced breast cancer: incidence and local control. Int J Radiat Oncol Biol Phys 2010;77:1113-1119.
32.
Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, Cochran AJ, Cody HS 3rd, Edge SB, Galper S, Hayman JA, Kim TY, Perkins CL, Podoloff DA, Sivasubramaniam VH, Turner RR, Wahl R, Weaver DL, Wolff AC, Winer EP; American Society of Clinical Oncology: American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703-7720.
33.
Deliiski T: [Stage migration after biopsy of internal mammary sentinel lymph node in breast cancer patient]. Khirurgiia 2005:26-27.
34.
Mansel RE, Goyal A, Newcombe RG, Group AT: Internal mammary node drainage and its role in sentinel lymph node biopsy: the initial ALMANAC experience. Clin Breast Cancer 2004;5:279-284; discussion 285-276.
35.
Kohrt HE, Olshen RA, Bermas HR, Goodson WH, Wood DJ, Henry S, Rouse RV, Bailey L, Philben VJ, Dirbas FM, Dunn JJ, Johnson DL, Wapnir IL, Carlson RW, Stockdale FE, Hansen NM, Jeffrey SS; Bay Area SLN Study: New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 2008;8:66.
36.
Zeng J, Xie H, Lu Y, Feng Z, Li F: Clinical implications of micrometastasis detection in internal mammary nodes of breast cancer patients. Breast Care 2012;7:216-219.
37.
Sawai K, Nakajima H, Mizuta N, Sakaguchi K, Hachimine Y: [Key issues in sentinel node biopsy for breast cancer]. Gan To Kagaku Ryoho 2004;31:1271-1274.
38.
Conn CA, McMasters KM, Edwards MJ, Martin RC: Acceptance of sentinel lymph node biopsy of the breast by all general surgeons in Kentucky. Breast J 2005;11:231-235.
39.
Paredes P, Vidal-Sicart S, Zanon G, Pahisa J, Fernandez PL, Velasco M, Santamaria G, Ortin J, Duch J, Pons F: Clinical relevance of sentinel lymph nodes in the internal mammary chain in breast cancer patients. Eur J Nucl Med Mol Imaging 2005;32:1283-1287.
40.
Paganelli G, Galimberti V, Trifiro G, Travaini L, De Cicco C, Mazzarol G, Intra M, Rocca P, Prisco G, Veronesi U: Internal mammary node lymphoscintigraphy and biopsy in breast cancer. Q J Nucl Med 2002;46:138-144.
41.
Ogawa Y, Ishikawa T, Sawada T, Chung SH, Osaka H, Takashima T, Onoda N, Kato Y, Ochi H, Hirakawa K: Thoracoscopic internal mammary sentinel node biopsy for breast cancer. Surg Endosc 2003;17:315-319.
42.
Grabenbauer GG: Internal mammary nodes in invasive breast carcinoma. To treat or not to treat? Strahlenther Onkol 2004;180:690-694.
43.
Coombs NJ, Boyages J, French JR, Ung OA: Internal mammary sentinel nodes: ignore, irradiate or operate? Eur J Cancer 2009;45:789-794.
44.
Huang O, Wang L, Shen K, Lin H, Hu Z, Liu G, Wu J, Lu J, Shao Z, Han Q, Shen Z: Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy. Breast Cancer Res Treat 2008;107:379-387.
45.
Veronesi U, Marubini E, Mariani L, Valagussa P, Zucali R: The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. Eur J Cancer 1999;35:1320-1325.
46.
Fowble B, Hanlon A, Freedman G, Nicolaou N, Hoffman J, Sigurdson E, Boraas M, Torosian M, Goldstein L: Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer. Int J Radiat Oncol Biol Phys 2000;47:883-894.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.